@article{3195259,
    title = "Atezolizumab (atezo) monotherapy versus chemotherapy in previously
untreated locally advanced or metastatic urothelial carcinoma (mUC):
Clinical outcomes by PD-L1 status in cisplatin (cis)-ineligible pts from
the phase III IMvigor130 study.",
    author = "Galsky, Matt D. and Bamias, Aristotelis and Arranz Arija, Jose Angel and and Davis, Ian D. and De Santis, Maria and Kikuchi, Eiji and del Muro, and Xavier Garcia and Park, Se Hoon and De Giorgi, Ugo and Alekseev, Boris and and Mencinger, Marina and Izumi, Kouji and Puente, Javier and Li Jian-Ri and and Mecke, Almut and Mariathasan, Sanjeev and Banchereau, Romain and and Huang Xinhui and Lee, Chooi Peng and Grande, Enrique",
    journal = "World Journal of Clinical Oncology",
    year = "2021",
    volume = "39",
    number = "6, S",
    publisher = "Lippincott, Williams & Wilkins",
    doi = "10.1200/JCO.2021.39.6_suppl.434"
}